Business Description
Eledon Pharmaceuticals is a clinical-stage biotech company based in Irvine, California, focused on developing treatments that work by blocking the CD40L biological pathway. Its primary drug candidate, tegoprubart, is being studied for its ability to prevent the body from rejecting transplanted kidneys and to treat ALS, a progressive neurological disease. The company also works with partners eGenesis and NewcelX on additional programs, including a cell-based treatment for Type 1 Diabetes.
